Vectoryl 4mg Tablet
PDF Leaflet Revision Date: 14 January 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Mild to moderate hypertension, congestive heart failure, cardiovascular risk reduction.
Dosage (summary)
4 mg once daily, may increase to 8 mg after one month; 2 mg for elderly or heart failure.
Onset of Action / Duration
Onset: 30 mins, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may harm fetus.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- Aliskiren
- Fluoroquinolones
Contraindications
- Hypersensitivity
- History of angioedema
- Severe renal impairment
- Bilateral renal artery stenosis
Common side effects
- Dizziness
- Hypotension
- Cough
- Abdominal pain
- Hyperkalaemia
Counselling Points
- Take before breakfast
- Monitor blood pressure
- Report signs of angioedema
Serious warnings
- Risk of hypotension
- Angioedema
- Dual blockade of RAAS contraindicated
Important Disclaimer
The Vectoryl 4mg Tablet professional information leaflet below is the property of Biogaran South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
